I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UP..:
Wright, Karen D
;
Zimmerman, Mary Ann
;
Fine, Elizabeth
...
Neuro-Oncology. 20 (2018) suppl_2 - p. i110-i110 , 2018
Link:
https://doi.org/10.1093/neuonc/noy059.367
RT Journal T1
LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY
UL https://suche.suub.uni-bremen.de/peid=cr-10.1093_neuonc_noy059.367&Exemplar=1&LAN=DE A1 Wright, Karen D A1 Zimmerman, Mary Ann A1 Fine, Elizabeth A1 Aspri, Tristan A1 Kieran, Mark W A1 Chi, Susan PB Oxford University Press (OUP) YR 2018 SN 1522-8517 SN 1523-5866 JF Neuro-Oncology VO 20 IS suppl_2 SP i110 OP i110 LK http://dx.doi.org/https://doi.org/10.1093/neuonc/noy059.367 DO https://doi.org/10.1093/neuonc/noy059.367 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)